实验方案(Protocols)

Recombinant Human GNAO1 Protein: Handling & Usage Protocol

Recombinant Human GNAO1 Protein is a highly purified G-protein alpha subunit expressed for use in G-protein signaling pathway studies, neuroscience research, and biochemical interaction assays.

Product Name
Recombinant Human GNAO1 Protein
SKU
rp367898
Protein Family
Heterotrimeric G-protein alpha subunit (Gi/Go family)
Recommended Storage
-80 °C for long-term storage; avoid repeated freeze-thaw cycles
Primary Applications
Biochemical assays, protein-protein interaction studies, G-protein signaling pathway research
Host Expression System
Recombinant expression system (see product datasheet for details)

Materials and Equipment Required

Before beginning, ensure the following materials are available:

  • Recombinant Human GNAO1 Protein (SKU: rp367898), stored at -80 °C until use
  • Sterile, nuclease-free water or the recommended reconstitution buffer (refer to the product datasheet for the specific buffer composition)
  • Microcentrifuge tubes (1.5 mL, low-protein-binding recommended)
  • Calibrated micropipettes and sterile tips
  • Microcentrifuge capable of ≥10,000 × g
  • Ice bucket or cooling block to maintain sample at 4 °C during handling
  • Protein quantification reagents (e.g., BCA or Bradford assay kit)
  • Appropriate assay buffers for downstream application (e.g., GTPase activity assay buffer, pull-down lysis buffer)

Note: Always consult the lot-specific Certificate of Analysis (CoA) and product datasheet supplied with the product for confirmed specifications before proceeding.

Reconstitution and Aliquoting Procedure

Follow these steps carefully to reconstitute and aliquot Recombinant Human GNAO1 Protein:

  1. Thawing: Remove the vial from -80 °C storage and allow it to thaw slowly on ice at 4 °C. Do not thaw at room temperature or use a water bath, as rapid temperature shifts may compromise protein activity.
  2. Centrifugation: Briefly centrifuge the vial (approximately 5–10 seconds at low speed) to collect any lyophilized material or liquid from the tube walls and cap.
  3. Reconstitution: Add the volume of sterile reconstitution buffer specified on the product datasheet dropwise to the vial. Gently swirl or pipette up and down to dissolve — do not vortex, as vigorous agitation can denature the protein.
  4. Equilibration: Allow the reconstituted protein to stand on ice for 5–10 minutes to ensure complete dissolution.
  5. Quantification: Determine protein concentration using a BCA or Bradford assay against a BSA standard curve to confirm expected concentration.
  6. Aliquoting: Divide the reconstituted protein into single-use aliquots using low-protein-binding tubes to minimize adsorption losses and avoid repeated freeze-thaw cycles.
  7. Storage of aliquots: Snap-freeze aliquots in liquid nitrogen and store at -80 °C. For short-term use within 1–2 weeks, aliquots may be kept at 4 °C.

Important: Repeated freeze-thaw cycles significantly reduce protein activity. Plan aliquot volumes according to your anticipated per-experiment usage.

Application Guidelines for G-Protein Signaling Assays

Recombinant Human GNAO1 Protein is suitable for a range of biochemical and cell-free assays investigating G-protein alpha subunit function. Typical applications include:

  • GTPase Activity Assays: GNAO1 exhibits intrinsic GTPase activity. Use the protein in GTP hydrolysis assays to characterize basal activity or the modulatory effect of RGS proteins or pharmacological agents. Optimize protein concentration empirically using pilot experiments.
  • Protein–Protein Interaction Studies: GNAO1 interacts with Gβγ subunits, GPCRs, RGS proteins, and effector molecules. The recombinant protein can be used in GST pull-down, co-immunoprecipitation (co-IP), or surface plasmon resonance (SPR) assays to map interaction interfaces.
  • Structural and Biophysical Studies: The purified protein is suitable as a reference standard or antigen in enzyme-linked immunosorbent assays (ELISA) and Western blot validation experiments.
  • Drug Screening: GNAO1 is a relevant target in neurological disease research. The recombinant protein can be used in competitive binding or activity-based screening platforms.

Optimization note: Optimal working concentrations vary by assay format. Always include appropriate positive and negative controls. Refer to peer-reviewed literature and the product datasheet for starting-point concentration recommendations.

Quality Control and Troubleshooting

To ensure experimental reliability, incorporate the following quality control (QC) checks:

IssuePossible CauseRecommended Action
Low or no detected activityProtein denaturation due to improper thawing or vortexingThaw on ice; reconstitute gently; do not vortex
Aggregation or precipitationExcess freeze-thaw cycles or incompatible bufferUse single-use aliquots; verify buffer composition against datasheet
Unexpected band size on SDS-PAGEDegradation or incorrect sample preparationRun fresh aliquot; check reducing vs. non-reducing conditions
Poor reproducibility between experimentsVariable protein concentration after reconstitutionRe-quantify each aliquot before use; standardize reconstitution volume

For further technical support, contact Aladdin Scientific's technical support team and reference SKU rp367898 and lot number from your CoA.

Safety, Disposal, and Regulatory Notes

Safety: Recombinant Human GNAO1 Protein is intended for research use only (RUO) and is not approved for human therapeutic, diagnostic, or veterinary use. Handle according to your institution's biosafety guidelines for recombinant proteins. Wear appropriate personal protective equipment (PPE) including gloves and a lab coat.

Disposal: Dispose of protein-containing waste in accordance with local institutional and governmental regulations for biological materials. Inactivate protein waste with appropriate methods (e.g., autoclaving or chemical inactivation) before disposal if required by your facility's biosafety protocol.

Regulatory: This product is supplied for research purposes only. Users are responsible for compliance with all applicable local, national, and international regulations governing the use of recombinant proteins in their jurisdiction.

Frequently asked questions

What is the recommended reconstitution buffer for Recombinant Human GNAO1 Protein?

The specific reconstitution buffer and volume are provided on the product datasheet and lot-specific Certificate of Analysis (CoA) supplied with SKU rp367898. Always follow the lot-specific instructions, as formulations may vary. If you do not have the datasheet, contact Aladdin Scientific technical support.

How many freeze-thaw cycles can Recombinant Human GNAO1 Protein tolerate?

To preserve protein activity and integrity, it is strongly recommended to minimize freeze-thaw cycles by preparing single-use aliquots prior to freezing. As a general best practice for recombinant G-protein subunits, repeated freeze-thaw cycles (typically more than 2–3) can lead to significant loss of activity and protein aggregation. Refer to the product datasheet for lot-specific guidance.

What downstream assays is Recombinant Human GNAO1 Protein validated for?

Recombinant Human GNAO1 Protein (rp367898) is suitable for applications including GTPase activity assays, protein-protein interaction studies (pull-down, co-IP, SPR), ELISA, and Western blot as a reference antigen. Validated applications are confirmed on the product datasheet; contact Aladdin Scientific for application-specific technical guidance.

What is the biological significance of GNAO1?

GNAO1 encodes the alpha subunit of the Go heterotrimeric G-protein, which is abundantly expressed in the nervous system and is a key mediator of GPCR signaling. It plays critical roles in neurotransmission, neuronal differentiation, and ion channel regulation. Mutations in GNAO1 are associated with early-onset epilepsy and movement disorders in humans, making it a target of significant clinical interest.

How should I confirm the identity and purity of my GNAO1 protein upon receipt?

Upon receipt, verify the protein identity and purity by running a small aliquot on an SDS-PAGE gel and comparing the band size to the predicted molecular weight stated in the CoA. Cross-reference the observed purity with the CoA specification. For functional confirmation, a GTPase activity assay or binding assay with a known interactor is recommended. Store the protein immediately at -80 °C if not used right away.

References

  1. Jiang M, Bajpayee NS. Molecular mechanisms of Go signaling. Neurosignals. 2009;17(1):23-41.
  2. Saitsu H, et al. De novo mutations in GNAO1 cause a severe neurological disorder with epilepsy, intellectual disability, and movement disorder. American Journal of Human Genetics. 2016.
  3. Gilman AG. G proteins: transducers of receptor-generated signals. Annual Review of Biochemistry. 1987;56:615-649.

Products are supplied for research and development use only. Not for use in humans, animals, diagnosis, or therapy.

目录: 实验方案(Protocols)

Da — 若无特别说明,分子量单位默认为道尔顿。   Mw — 重均分子量。   Mn — 数均分子量。

产品仅供科研与开发使用,不用于人体、动物、诊断或治疗。

引用本文

阿拉丁科学.《Recombinant Human GNAO1 Protein: Handling & Usage Protocol》. 阿拉丁知识库,更新于 2026年10月31日。 https://www.aladdin-e.com/zh_cn/faqs/recombinant-human-gnao1-protein-handling-usage-protocol-en.html
这篇文章对您有帮助吗? Yes No 有 3 人觉得有帮助